Similar articles

• Economic aspects of diabetic foot care in a multidisciplinary setting: a review.

  Matricali GA, Dereymaeker G, Muls E, Flour M, Mathieu C. Matricali GA, et al. Diabetes Metab Res Rev. 2007 Jul;23(5):339-47. doi: 10.1002/dmrr.706. Diabetes Metab Res Rev. 2007. PMID: 17103490 Review.
• An evidence-based model comparing the cost-effectiveness of platelet-rich plasma gel to alternative therapies for patients with nonhealing diabetic foot ulcers.

  Dougherty EJ. Dougherty EJ. Adv Skin Wound Care. 2008 Dec;21(12):568-75. doi: 10.1097/01.ASW.0000323589.27605.71. Adv Skin Wound Care. 2008. PMID: 19065083
• Diabetic foot: a major medical, social and economic problem in patients with diabetes.

  Suastika K. Suastika K. Acta Med Indones. 2005 Oct-Dec;37(4):185-6. Acta Med Indones. 2005. PMID: 16355514 No abstract available.
• International Diabetes Federation meeting, 1997. Neuropathy, information technology, cost of diabetes care, and epidemiology.

  Bloomgarden ZT. Bloomgarden ZT. Diabetes Care. 1998 Jul;21(7):1198-202. doi: 10.2337/diacare.21.7.1198. Diabetes Care. 1998. PMID: 9653620 No abstract available.
• The neuropathic diabetic foot.

  Rathur HM, Boulton AJ. Rathur HM, et al. Nat Clin Pract Endocrinol Metab. 2007 Jan;3(1):14-25. doi: 10.1038/ncpendmet0347. Nat Clin Pract Endocrinol Metab. 2007. PMID: 17179926 Review.